Three-year probabilities of PFS after intermediate intensity dCBT (n = 90). Three-year PFS and OS (A), 3-year GRFS (B), 3-year PFS according to age (split at 50 years) (C), European vs non-European ancestry (D), HCT-CI (low score of 0-2 vs 3-8) (E), rDRI (low-intermediate vs high-very high) (F), engrafting unit infused CD34⁺ cell dose (split at the median) (G), and engrafting unit-recipient 8-allele HLA match (H).